Nano-X Imaging (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp. to support the deployment of the Nanox.ARC across New England. This strategic move is designed to increase access to the FDA-cleared, multisource 3D digital tomosynthesis system in outpatient and community-based clinical settings, leveraging Associated X-Ray Imaging's regional customer relationships and service infrastructure.
The agreement marks a significant expansion of Nanox's U.S. channel partner network and underscores the company's commitment to broadening the reach of medical imaging beyond traditional hospital environments. By partnering with Associated X-Ray Imaging, Nanox aims to streamline the adoption of the Nanox.ARC in targeted markets, potentially improving early detection and clinical efficiency for healthcare providers in the region.
The Nanox.ARC is a cost-effective imaging system designed for ease of use and scalability, intended to bring advanced 3D imaging capabilities to a wider range of clinical settings. This technology is part of Nanox's integrated ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management and advanced imaging analytics; and Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services.
The importance of this distribution agreement lies in its potential to enhance access to preventive health care. By making the Nanox.ARC more readily available in outpatient and community settings, Nanox is working to lower barriers to adoption and improve utilization of advanced imaging. This aligns with the company's vision of expanding the reach of medical imaging both within and beyond traditional hospital settings, providing a seamless solution from scan to interpretation and beyond.
Nanox's integrated approach combines imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology to support earlier detection of disease and improve patient outcomes. The company's focus on preventive health care is a response to the growing need for more accessible and efficient diagnostic tools. With this new partnership, Nanox is poised to make significant inroads in the New England market, potentially setting a precedent for further regional expansions.
For more information on this development, visit https://nnw.fm/ChGtd. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX.
